WK Health System seeks participants in COVID-19 prevention pill research study


[ad_1]

EDITOR’S NOTE: Dr Joseph Bocchini, who leads the study for the Willis Knighton Healthcare System, said early Monday afternoon that the trial has been postponed until some adjustments can be made to the way the study is conducted. Willis Knighton will provide an update when recruitment for the clinical trial resumes.

SHREVEPORT, Louisiana – (KTAL / KMSS) – The Willis-Knighton Health System, one of 400 sites across the country selected to be part of a clinical research study on a new COVID-19 pill, is looking for participants to join the study.

Each selected person will receive a small allowance for the time and travel necessary for their participation.

The study aims to determine whether a drug taken by mouth will prevent COVID-19 disease in people who are household contacts of a patient recently diagnosed with symptomatic COVID-19.

“We are studying this antiviral drug to see if it can protect people exposed to COVID-19 from infection,” said Joseph Bocchini, MD. Dr Bocchini is the study’s principal investigator.

Those eligible to participate must be 18 years of age or older, have no current symptoms of COVID-19, and reside in the same household as a person with symptoms of COVID-19 infection who has recently been diagnosed virus, ”said Carrie Kay, RN. , CCRC, Director of Clinical Research for the Willis-Knighton Health System.

Patients who have had COVID-19, have liver or kidney disease, cancer or any other current infection are not eligible, Kay added.

Participants will be randomly assigned to receive the drug or oral placebo twice a day for five or 10 days.

Research visits will be conducted free of charge by medical professionals at the WK COVID Research Center.

In addition, participants will be monitored at home and tested throughout the study.

Click here to learn more about this clinical trial or call Carrie Kay at (318) 455-9730.

Download the ArkLaTexHomepage application to keep up with the latest news, breaking news, weather, sports and more!

[ad_2]

Paul N. Strickland